Total planned funding: $373,330,604
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $373,330,604 |
Organizational Types
NGO | $132,814,949 |
Private Contractor | $103,036,079 |
Unknown | $48,595,785 |
Own Agency | $40,535,496 |
Implementing Agency | $33,983,370 |
FBO | $6,039,141 |
Multi-lateral Agency | $3,676,316 |
University | $3,184,468 |
Other USG Agency | $1,465,000 |
Program Areas
Treatment | $141,510,386 |
Care | $83,454,159 |
Prevention | $77,728,831 |
Testing | $36,979,086 |
Management and Operations | $23,954,895 |
Governance and Systems | $9,703,247 |
Budget Codes
HTXS: Treatment: Adult Treatment | $71,083,835 |
HTXD: Treatment: ARV Drugs | $63,412,557 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $58,617,467 |
HKID: Care: Orphans and Vulnerable Children | $43,758,132 |
HVCT: Testing: HIV Testing and Counseling | $36,979,086 |
HBHC: Care: Adult Care and Support | $24,545,420 |
HVMS: Management and Operations | $23,954,895 |
HVOP: Sexual Prevention: Other Sexual Prevention | $13,680,736 |
HVTB: Care: TB/HIV | $10,004,308 |
PDTX: Treatment: Pediatric Treatment | $7,013,994 |
HVSI: Strategic Information | $5,490,285 |
PDCS: Care: Pediatric Care and Support | $5,146,299 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,402,005 |
OHSS: Health Systems Strengthening | $2,526,347 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,028,623 |
HLAB: Laboratory Infrastructure | $1,686,615 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$97,761,104
Countries/Regions
University of Washington:
$44,572,651
Countries/Regions
USG Aggregated Agencies:
$40,535,496
Countries/Regions